All

European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests €3.5M ($3.9M) to prepare the next growth phase
28 May 2019

European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests €3.5M ($3.9M) to prepare the next growth phase

Domain Therapeutics announces today that it has secured a €3.5M ($3.9M) investment from existing shareholder Seventure Partners, to accelerate its next growth phase. Since...

Read the press release
Vedanta Biosciences Closes Extended $45.5 Million Series C Financing
13 May 2019

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...

Read more
Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
8 May 2019

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

Upheld patent EP2575835 covers therapeutic compositions of clostridial bacterial species derived from the human microbiome. Decision further solidifies Vedanta’s leading IP...

Read more
Seventure Partners invests $3,4m in the British remittance company TransferGo
7 May 2019

Seventure Partners invests $3,4m in the British remittance company TransferGo

TransferGo hits landmark milestone following successful Series B funding round and an additional $3.4 million investment from Seventure Partners

Read the press release
KEEN EYE Raises EUR 6 Millions to Empower Biomedical Labs with AI
30 April 2019

KEEN EYE Raises EUR 6 Millions to Empower Biomedical Labs with AI

This funding will enable the company to deploy internationally its latest machine learning technologies for laboratories and biomedical research.

Read the press release
Mdoloris Announces CE Marking of the Analgesia Nociception Index (ANI®) Module for the Masimo Root® Patient Monitoring and Connectivity Hub
29 April 2019

Mdoloris Announces CE Marking of the Analgesia Nociception Index (ANI®) Module for the Masimo Root® Patient Monitoring and Connectivity Hub

ANI provides an objective, noninvasive, and continuous way to automatically monitor the pain level of patients. The Root platform, with its open architecture and built-in...

Read the press release
Enterome announces research collaboration with renowned US Cancer Institute focused on new microbiome-derived cancer immunotherapy
22 March 2019

Enterome announces research collaboration with renowned US Cancer Institute focused on new microbiome-derived cancer immunotherapy

New collaboration to evaluate the potential of bacterial antigens that mimic tumor antigens and neoantigens ("onco-mimics") to drive immune responses.

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse